Embrella lands CE Mark for embolic protection device

Kaitlyn Dmyterko | | Health Imaging | Diagnostic Imaging
The European Union has granted CE Mark of approval to Embrella Cardiovascular’s aortic embolic protection device Embolic Deflector, to be marketed throughout Europe.

According to Wayne, Pa.-based Embrella, the protection device acts as a protective shield against debris and calcifications that may embolize the brain during transcathter aortic valve implantation procedures.

The device has been previously approved in Europe for use in high-risk patients with severe aortic stenosis.

Kaitlyn Dmyterko

Related Content

AI rules out abnormal findings on chest X-rays, significantly reducing workloads
Older adults among the walking wounded with incident TBI
Philips moves digital pathology to the cloud with AWS
PHOTO GALLERY: What does fetal medical imaging look like?
Speaker laments radiology’s major contribution to climate change
Radiologist accuracy takes a hit overnight, especially with advanced imaging exams

Around the web

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.